ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,557,000 | +90.1% | 33,612 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $819,000 | +80.0% | 33,612 | +5.2% | 0.00% | +100.0% |
| Q4 2018 | $455,000 | -6.4% | 31,950 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $486,000 | -9.3% | 31,950 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $536,000 | -89.6% | 31,950 | -89.9% | 0.00% | -92.9% |
| Q1 2018 | $5,154,000 | +8.0% | 315,800 | -15.3% | 0.01% | +7.7% |
| Q4 2017 | $4,774,000 | -3.2% | 373,000 | -7.0% | 0.01% | -7.1% |
| Q3 2017 | $4,932,000 | +3.5% | 401,000 | -29.5% | 0.01% | 0.0% |
| Q2 2017 | $4,763,000 | -51.1% | 569,000 | -47.8% | 0.01% | -54.8% |
| Q1 2017 | $9,745,000 | +100.1% | 1,090,000 | +96.8% | 0.03% | +93.8% |
| Q4 2016 | $4,869,000 | – | 553,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |